LD 753 allocates $1 million annually from the General Fund to establish and maintain an adult treatment and recovery court in Aroostook County. This court will provide specialized judicial oversight and substance abuse treatment services for eligible county residents. The funding covers ongoing operational costs for the court program, directly supporting individuals seeking treatment for substance use disorders within Aroostook County. The bill focuses on creating a structured, court-supervised treatment pathway rather than changing existing laws or regulations.
This bill authorizes Maine's Finance Authority to issue $87 million in revenue bonds to fund upgrades at county jails and short-term holding facilities (detaining adults for up to 72 hours pending trial or for sentences under 72 hours). The bonds, not considered state debt, must be repaid by 2036 using 50% from spirit sales revenue and 50% from opioid settlement funds. Funds will specifically upgrade facilities to accommodate individuals with substance use disorders and support their treatment, while also addressing potential funding gaps for jails. The bill targets all county jails and holding facilities across Maine, with allocations based on jail population.
LD 1973 establishes a 15-member commission to study oversight and funding for recovery residences in Maine. The commission will examine five key areas: state funding models for recovery residences, potential certification/licensure requirements, policies around prescribed medications (including medication-assisted treatment), standards for the National Alliance for Recovery Residences, and other operational policies. This study directly affects recovery residences (both certified and uncertified), residents (particularly regarding medication access), housing advocates, and state agencies like Health and Human Services. The commission must submit findings and recommendations to the Health and Human Services committee by December 3, 2025, to inform future legislation.
LD 1646 amends Maine's Good Samaritan law to expand legal protection for people who call for help during suspected drug overdoses. It removes references to "medical emergencies" and instead covers any call for assistance regarding a person showing symptoms of an overdose (such as confusion, irregular breathing, or unresponsiveness). The bill grants immunity from arrest, prosecution, or revocation of probation for drug-related offenses if the person is identified during a response to such a call. This directly affects individuals seeking medical aid during suspected overdoses and encourages calling 911 without fear of legal consequences for minor drug offenses.
LD 793 proposes to update Maine's gaming revenue distribution system and boost funding for gambling addiction services. The bill would modernize how revenue from gambling activities is allocated, specifically increasing the share directed to the Gambling Addiction Prevention and Treatment Fund. This fund supports services like counseling and education programs aimed at preventing and treating gambling disorders. The changes would directly affect state budget allocations for addiction services and the distribution of revenue from Maine's casinos and lottery. (Note: This is a concept draft under consideration, not yet law.)
This bill changes Maine's estate recovery process for long-term care under MaineCare. It requires the state to refund the portion of recovered funds after deducting collection costs and federal Medicaid payments (effective January 2026), directly affecting estates of deceased MaineCare recipients. It lowers the evidence standard for asset transfers from "clear and convincing" to "preponderance of evidence" when proving transfers weren't made solely for Medicaid eligibility. The bill also mandates new educational materials for the public about estate recovery, long-term care planning, and family caregiver reimbursement programs, to be published by January 2026.
This bill requires Maine's Department of Health and Human Services to raise reimbursement rates for non-hospital detoxification services for substance use disorder treatment. By January 1, 2026, the department must update its rules to pay at least $594.38 per day for these services. The change directly affects substance use treatment facilities that provide medically supervised detox outside of hospitals. This policy adjustment aims to improve payment for critical early-stage treatment services under MaineCare.
This bill (LD 852) requires Maine county jails to provide mandated substance use disorder and mental health services, directly affecting all county correctional facilities. Key provisions include mandatory evidence-based screening, medication-assisted treatment (including all FDA-approved options), counseling, peer support, and reentry planning for inmates. The bill aims to shift funding responsibility from local property taxes to state-level funding by establishing these service standards, though it does not specify new state funding sources. This policy change focuses on improving inmate care and reducing local tax burdens through standardized jail operations.
LD 1530 requires Maine insurance companies to pay ambulance and nontransporting emergency medical services (EMS) providers specific reimbursement rates, including 200% of Medicare rates for in-network providers and 180% for out-of-network providers, with extra payments for rural areas. It prohibits insurers from requiring prior authorization for most ambulance transports to hospitals or facilities (like nursing homes) and ensures on-scene care - such as administering naloxone for opioid overdoses without transport - is reimbursed. The bill also limits annual rate increases for providers with rates below 200% of Medicare to 5% and clarifies that community paramedicine services may still require prior authorization. This directly affects EMS providers, rural communities, and patients receiving emergency care in Maine.
This bill exempts certain over-the-counter (OTC) medicines from Maine's sales tax starting January 1, 2026. It applies to FDA-approved OTC medicines meeting specific labeling requirements, including antacids, contraceptive products, allergy medications, eye/ear/nose treatments, and opioid antagonists. The exemption covers medicines sold directly to consumers without a prescription, but excludes cannabis products. This change affects Maine residents purchasing these specific OTC health products, reducing their out-of-pocket costs for essential medications.
